Literature DB >> 28385328

Adiponectin profile and Irisin expression in Italian obese children: Association with insulin-resistance.

Ersilia Nigro1, Olga Scudiero2, Maria Ludovica Monaco3, Rita Polito1, Pietro Schettino4, Anna Grandone5, Laura Perrone5, Emanuele Miraglia Del Giudice5, Aurora Daniele6.   

Abstract

Adiponectin (Acrp30), its high molecular weight (HMW) oligomers, and Irisin are molecules involved in several metabolic processes. To investigate if these cytokines could represent new metabolic markers, we evaluated the expression of Acrp30 and Irisin in serum of obese children from South Italy affected by different degrees of insulin resistance (IR). The anthropometric and metabolic features were evaluated in 27 obese children versus 13 age-matched controls. The expression of Acrp30, its pattern and Irisin were investigated by ELISA, western blotting and fast protein liquid chromatography. The HOMA index was significantly higher in obese children versus controls, and metabolic syndrome was more prevalent in obese children with elevated IR versus those with normal HOMA (38% vs 16%). Total Acrp30 and HMW oligomers were significantly lower in obese than in control children, and the difference was more pronounced in children with HOMA >3.4. In control and obese children, total Acrp30 and HMW oligomers were inversely related to HOMA (r-0.38, p 0.02; r-0.35, p 0.03). Irisin was significantly higher in obese than in control children, and was inversely correlated with Acrp30 and HMW (r-0.32, p 0.04; r-0.39, p 0.01). The inverse correlation of Acpr30 and HMW oligomers with HOMA indicates that Acpr30 is directly involved in IR status. Moreover, the inverse correlation between Irisin and Acrp30 and, more significantly, between Irisin and HMW oligomers suggests that the two cytokines are closely connected. The use of Acrp30, HMW oligomers and Irisin as predictive factors of IR in obese children remains to be further elucidated.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adiponectin; Childhood obesity; HMW oligomers; Insulin resistance; Irisin

Mesh:

Substances:

Year:  2017        PMID: 28385328     DOI: 10.1016/j.cyto.2016.12.018

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  14 in total

Review 1.  Irisin in metabolic diseases.

Authors:  Stergios A Polyzos; Athanasios D Anastasilakis; Zoe A Efstathiadou; Polyzois Makras; Nikolaos Perakakis; Jannis Kountouras; Christos S Mantzoros
Journal:  Endocrine       Date:  2017-11-23       Impact factor: 3.633

2.  Circulating Irisin in Children and Adolescents With Prader-Willi Syndrome: Relation With Glucose Metabolism.

Authors:  Stefania Mai; Danilo Fintini; Chiara Mele; Alessio Convertino; Sarah Bocchini; Graziano Grugni; Gianluca Aimaretti; Roberta Vietti; Massimo Scacchi; Antonino Crinò; Paolo Marzullo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-14       Impact factor: 6.055

3.  Implications of the Adiponectin System in Non-Small Cell Lung Cancer Patients: A Case-Control Study.

Authors:  Ersilia Nigro; Fabio Perrotta; Maria Ludovica Monaco; Rita Polito; Pia Clara Pafundi; Maria Gabriella Matera; Aurora Daniele; Andrea Bianco
Journal:  Biomolecules       Date:  2020-06-18

4.  Myokine-adipokine cross-talk: potential mechanisms for the association between plasma irisin and adipokines and cardiometabolic risk factors in Mexican children with obesity and the metabolic syndrome.

Authors:  Adrian M Gonzalez-Gil; Mariana Peschard-Franco; Elena C Castillo; Gustavo Gutierrez-DelBosque; Victor Treviño; Christian Silva-Platas; Luisa Perez-Villarreal; Gerardo Garcia-Rivas; Leticia Elizondo-Montemayor
Journal:  Diabetol Metab Syndr       Date:  2019-08-05       Impact factor: 3.320

Review 5.  Irisin: A Hope in Understanding and Managing Obesity and Metabolic Syndrome.

Authors:  Lidia I Arhire; Laura Mihalache; Mihai Covasa
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-02       Impact factor: 5.555

6.  Decreased Blood Asprosin in Hyperglycemic Menopausal Women as a Result of Whole-Body Cryotherapy Regardless of Metabolic Syndrome.

Authors:  Magdalena Wiecek; Jadwiga Szymura; Justyna Sproull; Zbigniew Szygula
Journal:  J Clin Med       Date:  2019-09-10       Impact factor: 4.241

7.  Association of Total and High Molecular Weight Adiponectin with Components of Metabolic Syndrome in Mexican Children

Authors:  Javier A. Magaña Gomez; Daniela Moreno-Mascareño; Carla E. Angulo Rojo; Gisela Duarte de la Peña
Journal:  J Clin Res Pediatr Endocrinol       Date:  2019-09-25

Review 8.  Dietary Thiols: A Potential Supporting Strategy against Oxidative Stress in Heart Failure and Muscular Damage during Sports Activity.

Authors:  Mariarita Brancaccio; Cristina Mennitti; Arturo Cesaro; Fabio Fimiani; Elisabetta Moscarella; Martina Caiazza; Felice Gragnano; Annaluisa Ranieri; Giovanni D'Alicandro; Nadia Tinto; Cristina Mazzaccara; Barbara Lombardo; Raffaela Pero; Giuseppe Limongelli; Giulia Frisso; Paolo Calabrò; Olga Scudiero
Journal:  Int J Environ Res Public Health       Date:  2020-12-16       Impact factor: 3.390

9.  Short-Term Physiological Effects of a Very Low-Calorie Ketogenic Diet: Effects on Adiponectin Levels and Inflammatory States.

Authors:  Vincenzo Monda; Rita Polito; Annarita Lovino; Antonio Finaldi; Anna Valenzano; Ersilia Nigro; Gaetano Corso; Francesco Sessa; Alessio Asmundo; Nunzio Di Nunno; Giuseppe Cibelli; Giovanni Messina
Journal:  Int J Mol Sci       Date:  2020-05-02       Impact factor: 5.923

10.  Circulating Irisin and esRAGE as Early Biomarkers of Decline of Metabolic Health.

Authors:  Elena Dozio; Elena Vianello; Clementina Sitzia; Federico Ambrogi; Stefano Benedini; Silvia Gorini; Benedetta Rampoldi; Roberta Rigolini; Lorenza Tacchini; Massimiliano Marco Corsi Romanelli
Journal:  J Clin Med       Date:  2020-02-06       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.